Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

References

• You D, Hug L, Ejdemyr S, Idele P, Hogan D, Mathers C, Gerland P, New JR, Alkema L. 2015. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN inter-agency group for child mortality estimation. Lancet. 386:2275–2286. doi:https://doi.org/10.1016/S0140-6736(15)00120-8.
   PubMed Web of Science ®Google Scholar
• Walker CL, Aryee MJ, Boschi-Pinto C, Black RE, Myer L. 2012. Estimating diarrhea mortality among young children in low- and middle-income countries. PLoS ONE. 7:e29151. doi:https://doi.org/10.1371/journal.pone.0029151.
   PubMed Web of Science ®Google Scholar
• GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1151–1210. doi:https://doi.org/10.1016/S0140-6736(17)32152-9.
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(S2):S96–105. doi:https://doi.org/10.1093/cid/civ1013.
   PubMed Web of Science ®Google Scholar
• Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. The changing epidemiology of rotavirus and its role as the leading cause of diarrhea burden among children under 5 years old. JAMA Pediatr. 2018 Aug 13. doi:https://doi.org/10.1001/jamapediatrics.2018.1960.
   Google Scholar
• Clark A, Black R, Tate J, Roose A, Kotloff K, Lam D, Blackwelder W, Parashar U, Lanata C, Kang G, et al. Estimating global, regional and national rotavirus deaths in children aged <5 years: current approaches, new analyses and proposed improvements. PLoS ONE. 2017;12(9):e0183392.
   PubMed Web of Science ®Google Scholar
• Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD. 2012. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine. 30:A7–14. doi:https://doi.org/10.1016/j.vaccine.2011.12.096.
   PubMed Web of Science ®Google Scholar
• Bertram MY, Lauer JA, de Joncheere KD, Edejer T, Hutubessy R, Kieny M-P, Hill SR. 2016. Cost effectiveness thresholds: pros and Cons. Bull WHO. 94:925–930. doi:https://doi.org/10.2471/BLT.15.164418.
   PubMed Web of Science ®Google Scholar
• Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD. Estimating reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Exp Rev Vaccines. 2017;16(10):987–995. doi:https://doi.org/10.1080/14760584.2017.1371595.
   PubMed Web of Science ®Google Scholar
• Burnett E, Tate JE, Kirkwood CD, Nelson EAS, Santosham M, Steele AD, Parashar UD. Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia. Exp Rev Vaccines. 2018;17(5):453–460.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. 2007. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomized, double-blind controlled study. Lancet. 370:1757–1763. doi:https://doi.org/10.1016/S0140-6736(07)61744-9.
   PubMed Web of Science ®Google Scholar
• Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. Human rotavirus vaccine study group. N Engl J Med. 2006;354:11–22.
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, Nelson EAS, Huang LM, Quak SH, Lee BW, van Doorn LJ, Teoh YL, Tang H, et al. 2012. Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine. 30:4552–4557. doi:https://doi.org/10.1016/j.vaccine.2012.03.030.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele AD, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. 2010. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 362:289–298. doi:https://doi.org/10.1056/NEJMoa0904797.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. 2006. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 354:23–33. doi:https://doi.org/10.1056/NEJMoa052664.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow S, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. 2010. Efficacy of the pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomized, double blind placebo-controlled trial. Lancet. 376:606–614. doi:https://doi.org/10.1016/S0140-6736(10)60889-6.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TPM, Luby SP, et al. 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomized, double blind, placebo-controlled trial. Lancet. 376:615–623. doi:https://doi.org/10.1016/S0140-6736(10)60755-6.
   PubMed Web of Science ®Google Scholar
• WHO. 2009. Rotavirus vaccines: An update. Weekly Epidemiol Rec. 84:533–540.
   PubMedGoogle Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human bovine (116E) rotavirus vaccine in India infants: A randomized, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136–2143. doi:https://doi.org/10.1016/S0140-6736(13)62630-6.
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Danovaro-Holliday MC, Andrus JK, de Fillipis AMB, Gentsch J, Matus CR, Widdowson M-A. Sentinel hospital surveillance for rotavirus in Latin American and Caribbean countries. J Infect Dis. 2009;200 Suppl 1(Suppl 1):S131–9. doi:https://doi.org/10.1086/605060.
   PubMedGoogle Scholar
• Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, Parashar UD. 2009. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 124:465–471. doi:https://doi.org/10.1542/peds.2008-3528.
   PubMed Web of Science ®Google Scholar
• Karafillakisa E, Hassounaha S, Atchisonb C. 2015. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 33:2097–2107. doi:https://doi.org/10.1016/j.vaccine.2015.03.016.
   PubMed Web of Science ®Google Scholar
• Richardson V, Parashar U, Patel M. 2011. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med. 365:772–773. doi:https://doi.org/10.1056/NEJMc1100062.
   PubMed Web of Science ®Google Scholar
• Do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Hage Carmo E, et al. 2011. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 8:e1001024. doi:https://doi.org/10.1371/journal.pmed.1001024.
   PubMed Web of Science ®Google Scholar
• Bhan MK, Glass RI, Ella KM, Bhandari N, Boslego J, Greenberg HB, Mohan K, Curlin G, Rao TS. Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development. Lancet. 2014;383(9935):2180–2183. doi:https://doi.org/10.1016/S0140-6736(14)60191-4.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Steele AD. 2017. Rotavirus vaccine will have an impact in Asia. PLoS Med. 14:e1002298. doi:https://doi.org/10.1371/journal.pmed.1002230.
   PubMed Web of Science ®Google Scholar
• WHO. 2013. Rotavirus vaccines position paper January 2013. WER. 88:49–64.
   Google Scholar
• Zaman K, Sack DA, Neuzil KM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, et al. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster randomized trial. PLoS Med. 2017;14(4):e1002282. doi:https://doi.org/10.1371/journal.pmed.1002230.
   PubMed Web of Science ®Google Scholar
• Jonesteller CL, Burnett E, Yen C, Parashar U. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global post-licensure data, 2006-2016. Clin Infect Dis. 2017;65:840–850. doi:https://doi.org/10.1093/cid/cix369.
   PubMed Web of Science ®Google Scholar
• Paterina-Caicedo A, Parashar UD, Alvis-Guzmán N, De Oliveira LH, Castaño-Zuluaga A, Cotes-Cantillo K, Gamboa-Garay O, Coronell-Rodríguez W, De la Hoz-Restrepo F. 2015. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. Vaccine. 33:3923–3928. doi:https://doi.org/10.1016/j.vaccine.2015.06.058.
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Giglio N, Ciapponi A, García Martí S, Kuperman M, Sanwogou NJ, Ruiz-Matus C, Marinho de Sousa MF. Temporal trends in diarrhea related hospitalizations and deaths in children under 5 before and after the introduction of rotavirus vaccine in four Latin American countries. Vaccine. 2013;31(Suppl 3):C99–108. doi:https://doi.org/10.1016/j.vaccine.2013.05.065.
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH, Tate J, Leshem E, Mercado J, Umaña J, Balmaceda A, Reyes M, Kerin T, et al. 2016. Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua. Clin Infect Dis. 62 Suppl 2:S127–32. doi:https://doi.org/10.1093/cid/civ1017.
   PubMed Web of Science ®Google Scholar
• Sahakyan G, Grigoryan S, Wasley A, Mosina L, Sargsyan S, Asoyan A, Gevorgyan Z, Kocharyan K, Avagyan T, Lopman B, et al. 2016. Impact and effectiveness of monovalent rotavirus vaccine in Armenian children. Clin Infect Dis. 62 Suppl 2:S147–54. doi:https://doi.org/10.1093/cid/ciw045.
   PubMed Web of Science ®Google Scholar
• Gheorghota S, Birca L, Donos A, Wasley A, Birca I, Cojocaru R, Melnick A, Ciobanu S, Mosina L, Cortese MM, et al. 2016. Impact of rotavirus vaccine introduction and vaccine effectiveness in the Republic of Moldova. Clin Infect Dis. 62:S140–46. doi:https://doi.org/10.1093/cid/civ1209.
   PubMed Web of Science ®Google Scholar
• Armah GE, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, Narh C, Lartey B, Binka F, Grytdal S, et al. 2016. Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus diarrhea in Ghana. Clin Infect Dis. 62:S200–07. doi:https://doi.org/10.1093/cid/ciw014.
   PubMed Web of Science ®Google Scholar
• Mpabalwani EM, Simwaka CJ, Mwenda JM, Mubanga CP, Monze M, Matapo B, Parashar UD, Tate JE. 2016. Impact of rotavirus vaccination on diarrheal hospitalizations in children aged <5 years in Lusaka, Zambia. Clin Infect Dis. 62:S183–87. doi:https://doi.org/10.1093/cid/civ1027.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, et al. 2015. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis. 15:422–428. doi:https://doi.org/10.1016/S1473-3099(14)71060-6.
   PubMed Web of Science ®Google Scholar
• Ngabo F, Tate JE, Gatera M, Rugambwa C, Donnen P, Lepage P, Mwenda JM, Binagwaho A, Parashar UD. 2016. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis. Lancet Glob Health. 4:e129–36. doi:https://doi.org/10.1016/S2214-109X(15)00270-3.
   PubMed Web of Science ®Google Scholar
• Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ. 2011. Economic evaluations of rotavirus immunization for developing countries: a review of the literature. Expert Rev Vaccines. 10:1037–1051. doi:https://doi.org/10.1586/erv.11.65.
   PubMed Web of Science ®Google Scholar
• Rheingans R, Amaya M, Anderson JD, Chakraborty P, Atem J. 2014. Systematic review of the economic value of diarrheal vaccines. Hum Vaccin Immunother. 10:1582–1594. doi:https://doi.org/10.4161/hv.29352.
   PubMed Web of Science ®Google Scholar
• Smith ER, Rowlinson EE, Iniguez V, Etienne KA, Rivera R, Mamani N, Rheingans R, Patzi M, Halkyer P, Leon JS. 2011. Cost-effectiveness of rotavirus vaccination in Bolivia from the State perspective. Vaccine. 29:6704–6711. doi:https://doi.org/10.1016/j.vaccine.2011.05.038.
   PubMed Web of Science ®Google Scholar
• Ngabo F, Mvundura M, Gazley L, Gatera M, Rugambwa C, Kayonga E, Tuyishime Y, Niyibaho J, Mwenda JM, Donnen P, et al. 2016. The economic burden attributable to a child’s inpatient admission for diarrheal disease in Rwanda. PLoS ONE. 11:e0149805. doi:https://doi.org/10.1371/journal.pone.0149805.
   PubMed Web of Science ®Google Scholar
• Diop A, Atherly D, Faye A, Lamine Sall F, Clark AD, Nadiel L, Yade B, Ndiaye M, Fafa Cissé M, Ba M. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: a country-led analysis. Vaccine. 2015;33(Suppl 1):A119–25. doi:https://doi.org/10.1016/j.vaccine.2014.12.065.
   PubMed Web of Science ®Google Scholar
• Sigei C, Odaga J, Mvundura M, Madrid Y, Clark AD. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Vaccine. 2015;33(Suppl 1):A109–18. doi:https://doi.org/10.1016/j.vaccine.2014.12.079.
   PubMed Web of Science ®Google Scholar
• Bar-Zeev N, Tate JE, Pecenka C, Chikafa J, Mvula H, Wachepa R, Mwansambo C, Mhango T, Chirwa G, Crampin AC, et al. 2016. Cost-effectiveness of monovalent rotavirus vaccination in Malawi: a post-introduction analysis using individual patient level costing data. Clin Infect Dis. 62:S220–28. doi:https://doi.org/10.1093/cid/civ1025.
   PubMed Web of Science ®Google Scholar
• Nonvignon J, Atherly DE, Pecenka C, Aikins M, Gazley L, Groman D, Narh CT, Armah G. Cost-effectiveness of rotavirus vaccination in Ghana: examining impacts from 2012 to 2031. Vaccine. 2017:S0264-410X(17)31723–1. doi:https://doi.org/10.1016/j.vaccine.2017.11.080.
   Google Scholar
• Arwani P, Debellut F, Pecenka C, Anwari P, Debellut F, Pecenka C, Parwiz SM, Clark A, Groman D, Safi N. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan. Vaccine. 2018.36(51):7769–7774
   Google Scholar
• Pecenka C, Parashar U, Tate JE, Khan JAM, Groman D, Chacko S, Shamsuzzaman M, Clark A, Atherly D. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh. Vaccine. 2017;35(32):3982–3987. doi:https://doi.org/10.1016/j.vaccine.2017.05.087.
   PubMed Web of Science ®Google Scholar
• Rheingans R, Anderson JD, Bagamian KH, Pecenka C. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People’s Democratic Republic. Vaccine. in press. available online. doi:https://doi.org/10.1016/j.vaccine.2018.02.009.
   Google Scholar
• Rheingans R, Anderson JD, Bagamian KH, Pecenka C. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan. Vaccine. in press. available online. doi:https://doi.org/10.1016/j.vaccine.2018.02.008.
   Google Scholar
• Cunliffe N, Bostock N, Bouckenooghe A, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, et al. 2012. Efficacy of the human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life. Vaccine. 30S:A36–43. doi:https://doi.org/10.1016/j.vaccine.2011.09.120.
   Web of Science ®Google Scholar
• Madhi SA, Louw C, Bos P, Bos P, Aspinall S, Bouckenooghe A, Neuzil KM, Steele AD. 2012. Efficacy and immunogenicity of two or three dose rotavirus vaccine regimen in South African children over two consecutive rotavirus seasons: a randomized double-blind placebo-controlled trial. Vaccine. 30S:A44–51. doi:https://doi.org/10.1016/j.vaccine.2011.08.080.
   Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. 2014. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 32S:A110–114. doi:https://doi.org/10.1016/j.vaccine.2014.04.079.
   Web of Science ®Google Scholar
• Cunliffe NA, Zaman K, Rodrigo C, Debrus S, Benninghoff B, Pemmaraju Venkata S, Han -H-H. 2014. Early exposure of infants to natural rotavirus infection: A review of studies with human rotavirus vaccine RIX4414. BMC Pediatr. 14:295–303. doi:https://doi.org/10.1186/s12887-014-0295-2.
   PubMed Web of Science ®Google Scholar
• Steele AD, Madhi SA, Cunliffe NA, Vesikari T, Phua KB, Lim FS, Nelson EAS, Lau Y-L, Huang L-M, Karkada N, et al. 2016. Incidence of rotavirus gastroenteritis by age in African, Asian and European children: relevance for timing of rotavirus vaccination. Hum Vaccines Immunother. 12:2406–2412. doi:https://doi.org/10.1080/21645515.2016.1179412.
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Kilgore PE, Bresee JS, Wasunna KM, Behbehani K, Davidson R, Kuzoe F, Pang L, Weerasuriya K, Bryceson AD. Epidemiology of rotavirus diarrhea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ. 76;1998:25–37.
   PubMed Web of Science ®Google Scholar
• Kang G, Arora R, Chitamber SD, Deshpande J, Gupte MD, Kulkarni M, Naik TN, Mukherji D, Venkatasubramaniam S, Gentsch JR, et al. 2009. Hospital surveillance of rotavirus in children. J Infect Dis. 200:S147–53. doi:https://doi.org/10.1086/605031.
   PubMed Web of Science ®Google Scholar
• Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, Jaffar S, Gomara MI, Gray JJ, Brown DWG, et al. 2011. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 365:337–346. doi:https://doi.org/10.1056/NEJMoa1006261.
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, de Oliveira LH, Umaña J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A, et al. 2012. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics. 130:e365–72. doi:https://doi.org/10.1542/peds.2011-3478.
   PubMed Web of Science ®Google Scholar
• Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, et al. 2013. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 132:e25–33. doi:https://doi.org/10.1542/peds.2012-3804.
   PubMed Web of Science ®Google Scholar
• Pringle KD, Patzi M, Tate JE, Iniguez Rojas V, Patel M, Inchauste Jordan L, Montesano R, Zarate A, De Oliveira L, Parashar U. 2016. Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013-2014. Clin Infect Dis. 62:S115–20. doi:https://doi.org/10.1093/cid/civ1026.
   PubMed Web of Science ®Google Scholar
• Gastanaduy PA, Contreras-Roldan I, Bernart C, López B, Benoit SR, Xuya M, Muñoz F, Desai R, Quaye O, Tam KI, et al. 2016. Effectiveness of monovalent and pentavalent rotavirus vaccines in Guatemala. Clin Infect Dis. 62:S121–26. doi:https://doi.org/10.1093/cid/civ1208.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Moyes J, Cortese M, Moyes J, Zar HJ, Kapongo CN, Mulligan C, Diedericks R, Cohen C, Fleming JA, et al. 2014. Effectiveness of monovalent rotavirus vaccine against hospitalization for acute rotavirus diarrhoea in South African children: a case control study. Lancet Infect Dis. 14:1096–1104. doi:https://doi.org/10.1016/S1473-3099(14)70940-5.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Zell ER, Solomon F, Nzenze S, Parashar UD, Izu A, Madhi SA. 2016. Temporal association of rotavirus vaccine introduction and reduction in all cause childhood diarrheal hospitalizations in South Africa. Clin Infect Dis. 62:S188–95. doi:https://doi.org/10.1093/cid/civ1204.
   PubMed Web of Science ®Google Scholar
• Sanchez-Uribe E, Esparaza-Aguilar M, Parashar UD, Richardson V. 2016. Sustained reduction in childhood diarrhea related mortality and hospitalizations in Mexico after rotavirus vaccine universalization. Clin Infect Dis. 62:S133–39. doi:https://doi.org/10.1093/cid/civ1205.
   PubMed Web of Science ®Google Scholar
• Donato CM, Cowley D, Snelling TL, Akopov A, Kirkness EF, Kirkwood CD. 2014. Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era. Emerg Microbes Infect. 3:e47. doi:https://doi.org/10.1038/emi.2014.47.
   PubMed Web of Science ®Google Scholar
• Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, et al. 2011. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis. 53:245–253. doi:https://doi.org/10.1093/cid/cir307.
   PubMed Web of Science ®Google Scholar
• Lopman BA, Curns AT, Yen C, Parashar UD. 2011. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis. 204:980–986. doi:https://doi.org/10.1093/infdis/jir492.
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Shippee DB, Weinrobe MH, Davila MD, Katz BZ, Reddy S, Cuyugan MGKP, Lee SY, Simons YM, Yogev R, et al. 2013. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis. 56:755–760. doi:https://doi.org/10.1093/cid/cis1010.
   PubMed Web of Science ®Google Scholar
• Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD. 2011. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J. 30:S25–9. doi:https://doi.org/10.1097/INF.0b013e3181fefdee.
   Web of Science ®Google Scholar
• Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. 2011. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine. 29:2791–2796. doi:https://doi.org/10.1016/j.vaccine.2011.01.104.
   PubMed Web of Science ®Google Scholar
• Hanquet G, Ducoffre G, Vergison A, Neels P, Sabbe M, Van Damme P, Van Herck K. 2011. Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine. 29:4698–4703. doi:https://doi.org/10.1016/j.vaccine.2011.04.098.
   PubMed Web of Science ®Google Scholar
• Msimang VM, Page NA, Groome MJ, Moyes J, Cortese MM, Seheri M, Kahn K, Chagan M, Madhi SA, Cohen C. 2013. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J. 32:1359. doi:https://doi.org/10.1097/INF.0b013e3182a72fc0.
   PubMed Web of Science ®Google Scholar
• Zaman K, Sack DA, Neuzil KM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, et al. 2017. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. PLoS Med. 14:e1002282. doi:https://doi.org/10.1371/journal.pmed.1002230.
   PubMed Web of Science ®Google Scholar
• Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, Jain V, Cunliffe NA, Nakagomi O, Kirkwood CD, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis. 2005;192(Suppl 1):S146–59. doi:https://doi.org/10.1086/431499.
   PubMed Web of Science ®Google Scholar
• Banyai K, Laszlo B, Vojdani J, Steele AD, Nelson EAS, Gentsch JR, Parashar UD. 2012. Systematic Review of regional and temporal trends in global rotavirus strain diversity in the pre-rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine. 30S:A122–30. doi:https://doi.org/10.1016/j.vaccine.2011.09.111.
   Web of Science ®Google Scholar
• Sanchez-Padilla E, Grais RF, Guerin PJ, Steele AD, Burny M-E, Luquero FJ. 2009. Burden of disease and circulating serotypes of rotavirus infection in Sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis. 9:567–576. doi:https://doi.org/10.1016/S1473-3099(09)70179-3.
   PubMed Web of Science ®Google Scholar
• Miles M, Lewis K, Kang G, Parashar UD, Steele AD. 2012. A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan. Vaccine. 30S:A131–3. doi:https://doi.org/10.1016/j.vaccine.2011.10.002.
   Web of Science ®Google Scholar
• Steele AD, Neuzil KM, Cunliffe NA, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J. 2012. Human rotavirus vaccine Rotarix, provides protection against diverse circulating rotavirus strains in African infants. BMC Infect Dis. 12:213. doi:https://doi.org/10.1186/1471-2334-12-166.
   PubMed Web of Science ®Google Scholar
• Correia JB, Patel M, Nakagomi O, Montenegro FMU, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T. 2010. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serologically-unrelated G2P[4] strains in Brazil. J Infect Dis. 201:363–369. doi:https://doi.org/10.1086/649843.
   PubMed Web of Science ®Google Scholar
• Breiman RF, Zaman K, Armah GE, Sow SO, Anh DD, Victor JC, Hille D, Ciarlet M, Neuzil KM. 2012. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy studies of the oral pentavalent rotavirus vaccine. Vaccine. 30S:A24–9. doi:https://doi.org/10.1016/j.vaccine.2011.08.124.
   Web of Science ®Google Scholar
• Leshem E, Lopman B, Glass R, Moyes J, Zar HJ, Kapongo CN, Mulligan C, Diedericks R, Cohen C, Fleming JA, et al. 2014. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 14:847–856. doi:https://doi.org/10.1016/S1473-3099(14)70940-5.
   PubMed Web of Science ®Google Scholar
• Linhares AC, Justino MCA. 2014. Rotavirus vaccination in Brazil: effectiveness and health impact 7 years post-introduction. Exp Rev Vaccines. 13:43–57. doi:https://doi.org/10.1586/14760584.2014.861746.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Boniface K, Barnes GL, Bishop RF. 2011. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the national immunization program of Australia. Pediatr Infect Dis J. 30:S48–53. doi:https://doi.org/10.1097/INF.0b013e3181fefd90.
   PubMed Web of Science ®Google Scholar
• Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD. 2011. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J. 30:S42–7. doi:https://doi.org/10.1097/INF.0b013e3181fefd78.
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M. 2009. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 4:1303–1316. doi:https://doi.org/10.2217/fmb.09.96.
   PubMed Web of Science ®Google Scholar
• Cowley D, Donato CM, Roczo-Farkas S, Kirkwood CD. 2016. Emergence of a novel equine-like G3P[8] inter-genogroup reassortant rotavirus strain associated with gastroenteritis in Australian children. J Gen Virol. 97:403–410. doi:https://doi.org/10.1099/jgv.0.000352.
   PubMed Web of Science ®Google Scholar
• Zeller M, Donato C, Trovão NS, Cowley D, Heylen E, Donker NC, McAllen JK, Akopov A, Kirkness EF, Lemey P, et al. 2015. Genome-wide evolutionary analyses of G1P[8] strains isolated before and after rotavirus vaccine introduction. Genome Biol Evol. 7:2473–2483. doi:https://doi.org/10.1093/gbe/evv157.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Boniface K, Richardson S, Taraporewala ZF, Patton JT, Bishop RF. 2008. Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and re-infection in children. J Med Virol. 80:1090. doi:https://doi.org/10.1002/(ISSN)1096-9071.
   PubMed Web of Science ®Google Scholar
• Vizzi E, Calvino E, Gonzalez R, Pérez-Schael I, Ciarlet M, Kang G, Estes MK, Liprandi F, Ludert JE. 2005. Evaluation of serum antibody responses against the rotavirus non-structural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection. Clin Diagn Lab Immunol. 12:1157–1163. doi:https://doi.org/10.1128/CDLI.12.10.1157-1163.2005.
   PubMedGoogle Scholar
• Holloway G, Coulson BS. 2013. Innate cellular responses to rotavirus infection. J Gen Virol. 94:1151–1160. doi:https://doi.org/10.1099/vir.0.051276-0.
   PubMed Web of Science ®Google Scholar
• Pitzer VE, Bilcke J, Heylen E, Crawford FW, Callens M, De Smet F, Van Ranst M, Zeller M, Matthijnssens J. 2015. Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium? Sci Rep. 5:18585. doi:https://doi.org/10.1038/srep18585.
   PubMed Web of Science ®Google Scholar
• Chan J, Nirwati H, Triasih R, Bogdanovic-Sakran N, Soenarto Y, Hakimi M, Duke T, Buttery JP, Bines JE, Bishop RF, et al. 2011. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine. 29:1242–1247. doi:https://doi.org/10.1016/j.vaccine.2010.11.087.
   PubMed Web of Science ®Google Scholar
• Appaiahgari MB, Glass R, Singh S, Taneja S, Rongsen-Chandola T, Bhandari N, Mishra S, Vrati S. 2014. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine. 32:651–656. doi:https://doi.org/10.1016/j.vaccine.2013.12.017.
   PubMed Web of Science ®Google Scholar
• Becker-Drepps S, Vilchez S, Velasquez D, Moon -S-S, Hudgens MG, Zambrana LE, Jiang B. 2015. Rotavirus-specific IgG antibodies from mothers’ serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J. 34:115–116. doi:https://doi.org/10.1097/INF.0000000000000481.
   PubMed Web of Science ®Google Scholar
• Moon SS, Groome MJ, Velasquez D, Parashar UD, Jones S, Koen A, van Niekerk N, Jiang B, Madhi SA. 2016. Pre-vaccination rotavirus serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants. Clin Infect Dis. 62:157–165. doi:https://doi.org/10.1093/cid/civ828.
   PubMed Web of Science ®Google Scholar
• Moon SS, Wang Y, Shane AL, Nguyen T, Ray P, Dennehy P, Baek LJ, Parashar U, Glass RI, Jiang B. 2010. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J. 29:919–923. doi:https://doi.org/10.1097/INF.0b013e3181e232ea.
   PubMed Web of Science ®Google Scholar
• Rongsen-Chandola T, Strand TA, Goyal N, Flem E, Rathore SS, Arya A, Winje BA, Lazarus R, Shanmugasundaram E, Babji S, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine. 2014;32(Suppl 1):A134–9. doi:https://doi.org/10.1016/j.vaccine.2014.04.078.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Moon SDS, Velasquez D, Jones S, Koen A, van Niekerk N, Jiang B, Parashar UD, Madhi SA. 2014. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 92:238–245. doi:https://doi.org/10.2471/BLT.13.128066.
   PubMed Web of Science ®Google Scholar
• Ali AS, Kazi AM, Cortese MM, Fleming JA, Moon S, Parashar UD, Jiang B, McNeal MM, Steele D, Bhutta Z, et al. 2015. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine: A randomized trial. PLoS ONE. 10:e0127622. doi:https://doi.org/10.1371/journal.pone.0127622.
   PubMed Web of Science ®Google Scholar
• Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, Nataro JP, Rosenberg IH, Ryan ET, Tarr PI, et al. 2014. Environmental enteric dysfunction: pathogenesis, diagnosis and clinical consequences. Clin Infect Dis. 59:S207–212. doi:https://doi.org/10.1093/cid/ciu485.
   PubMed Web of Science ®Google Scholar
• Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, Mychaleckyj JC, Kirkpatrick B, Colgate R, Carmolli M, et al. 2015. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2:1759–1766. doi:https://doi.org/10.1016/j.ebiom.2015.09.036.
   PubMed Web of Science ®Google Scholar
• Nordgren J, Nitiema LW, Ouermi D, Simpore J, Svensson L, Kapoor A. 2013. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS ONE. 8:e69557. doi:https://doi.org/10.1371/journal.pone.0069557.
   PubMed Web of Science ®Google Scholar
• Nordgren J, Sharma S, Bucardo F, Nasir W, Günaydın G, Ouermi D, Nitiema LW, Becker-Dreps S, Simpore J, Hammarström L, et al. 2014. Both Lewis and Secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis. 59:1567–1573. doi:https://doi.org/10.1093/cid/ciu633.
   PubMed Web of Science ®Google Scholar
• Lee B, Dickson DM, deCamp AC, Ross Colgate E, Diehl SA, Uddin MI, Sharmin S, Islam S, Bhuiyan TR, Alam M, et al. Histoblood group antigen phenotype determines susceptibility to genotype-specific rotavirus infections and impacts measures of rotavirus vaccine efficacy. J Infect Dis. 2018 Jan 30;217:1399–1407. doi:https://doi.org/10.1093/infdis/jiy054.
   PubMed Web of Science ®Google Scholar
• Harris VC, Armah GE, Fuentes S, Korpela KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, et al. 2017. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J Infect Dis. 215:34–41. doi:https://doi.org/10.1093/infdis/jiw518.
   PubMed Web of Science ®Google Scholar
• Armah GE, Lewis K, Cortese M, Parashar UD, Ansah A, Gazley L, Victor JC, McNeal MM, Binka F, Steele AD. 2016. A randomized controlled trial of the impact of alternative dosing schedules on the immune response to human rotavirus vaccine in rural Ghanaian infants. J Infect Dis. 213:1678–1685. doi:https://doi.org/10.1093/infdis/jiw023.
   PubMed Web of Science ®Google Scholar
• Harris V, Ali A, Fuentes S, Korpela K, Kazi M, Tate J, Parashar U, Wiersinga WJ, Giaquinto C, de Weerth C, et al. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan. Gut Microbes. 2018;9(2):93–101.
   Web of Science ®Google Scholar
• Parker EPK, Praharaj I, Zekavati A, Lazarus RP, Giri S, Operario DJ, Liu J, Houpt E, Iturriza-Gómara M, Kampmann B, et al. 2018. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine. 36:264–272. doi:https://doi.org/10.1016/j.vaccine.2017.11.031.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Puustunen L, Zeng S-Q, Szakal ED, Delem A, De Vos B. Efficacy of RIX4414 live atteuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J. 23;2004:937–943.
   PubMed Web of Science ®Google Scholar
• Salinas R, Perez-Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarzábal JP, Cervantes Y, Clemens SC, Damaso S, Hardt K, et al. 2005. Evaluation of the safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin Americam infants. Pedaitric Infect Dis J. 24:807–816. doi:https://doi.org/10.1097/01.inf.0000178294.13954.a1.
   PubMed Web of Science ®Google Scholar
• Ali SA, Kazi AM, Cortese MM, Fleming JA, Parashar UD, Jiang B, McNeal MM, Steele D, Bhutta Z, Zaidi A. 2014. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial. J Infect Dis. 210:1772–1779. doi:https://doi.org/10.1093/infdis/jiu335.
   PubMed Web of Science ®Google Scholar
• Steele AD, Reynders J, Scholtz F, Bos P, de Beer MC, Tumbo J, Van der Merwe CF, Delem A, De Vos B. 2010. Comparison of two different regimens (two doses versus three doses) in terms of reactogenicity and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 in South Africa infants. J Infect Dis. 202:S93–100. doi:https://doi.org/10.1086/653550.
   PubMedGoogle Scholar
• Zaman K, Fleming JA, Victor JC, Yunus M, Bari TIA, Azim T, Rahman M, Mowla SMN, Bellini WJ, McNeal M, et al. 2016. Noninterference of rotavirus vaccine with measles-rubella vaccine at 9 months of age and improvements in anti-rotavirus immunity: a randomized trial. J Infect Dis. 213:1686–1693. doi:https://doi.org/10.1093/infdis/jiw024.
   PubMed Web of Science ®Google Scholar
• Haidara FC, Tapia MD, Sow S, Doumbia M, Coulibaly F, Diallo F, Traoré A, Kodio M, Kelly CL, Fitzpatrick M, et al. Evaluation of a booster dose of pentavalent rotavirus vaccine co-administered with measles, yellow fever, and meningitis a vaccines in 9-month-old malian infants. J Infect Dis. 2018 Jul 13;218(4):606–613. doi:https://doi.org/10.1093/infdis/jiy215.
   PubMed Web of Science ®Google Scholar
• Burnett E, Lopman BA, Parashar UD. 2017. Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality. Vaccine. 35:7198–7203. doi:https://doi.org/10.1016/j.vaccine.2017.10.027.
   PubMed Web of Science ®Google Scholar
• WHO. 2015. Maternal and neonatal tetanus elimination: validation survey in 4 States and 2 Union Territories in India, May 2015. Weekly Epidemiol Rec. 90:589–608.
   PubMedGoogle Scholar
• Bines JE, At Thobari J, Satria CD, Handley A, Watts E, Cowley D, Nirwati H, Ackland J, Standish J, Justice F, et al. 2018. Human Neonatal Rotavirus Vaccine (RV3-BB) to target rotavirus from birth. N Engl J Med. 378:719–730. doi:https://doi.org/10.1056/NEJMoa1706804.
   PubMed Web of Science ®Google Scholar
• Vesikari T. 2015. Neonatal rotavirus vaccines making headway (Editorial). Lancet Infect Dis. 15:1362–1363. doi:https://doi.org/10.1016/S1473-3099(15)00295-9.
   PubMed Web of Science ®Google Scholar
• Shankar AH, Prasad AS. 1998. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 68:447–463. doi:https://doi.org/10.1093/ajcn/68.2.447S.
   PubMed Web of Science ®Google Scholar
• Albert MJ, Qadri F, Wahed MA, Ahmed T, Rahman ASMH, Ahmed F, Bhuiyan NA, Zaman K, Baqui AH, Clemens JD, et al. 2003. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis. 187:909–913. doi:https://doi.org/10.1086/368132.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Svennerholm AM, Al Tarique A, Sultana GNN, Qadri F. 2009. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine. 27:1433–1439. doi:https://doi.org/10.1016/j.vaccine.2008.12.036.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. 2009. The guy microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 9:313–323. doi:https://doi.org/10.1038/nri2515.
   PubMed Web of Science ®Google Scholar
• Kandasamy S, Chattha KS, Vlasova AN, Rajashekara G, Saif LJ. 2014. Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model. Gut Microbes. 5:639–651. doi:https://doi.org/10.4161/19490976.2014.969972.
   PubMed Web of Science ®Google Scholar
• Mao X, Gu C, Hu H, Tang J, Chen D, Yu B, He J, Yu J, Luo J, Tian G, et al. 2016. Dietary Lactobacillus rhamnosus GG supplementation improves the mucosal barrier function in the intestine of weaned piglets challenged by porcine rotavirus. PLoS ONE. 11:e0146312. doi:https://doi.org/10.1371/journal.pone.0146312.
   PubMed Web of Science ®Google Scholar
• Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, Babji S, Sarkar R, Kaliappan PS, Venugopal S, et al. 2018. A randomized double blind placebo-controlled trial of supplementation with Zinc and/or probiotics to enhance the immune response of oral rotavirus and polio vaccines in Indian infants. Vaccine. 36:273–295. doi:https://doi.org/10.1016/j.vaccine.2017.07.116.
   PubMed Web of Science ®Google Scholar
• Gavi. Rotavirus roadmap public summary. The market shaping goal. Supply Procure Roadmap – Rotavirus. 2013 Oct 31. www.gavialliance.org/.
   Google Scholar